B. Natarajan, N. Jayaraman / Journal of Organometallic Chemistry 696 (2011) 722e730
727
6.87 (d, J ¼ 8.4 Hz, 6 H), 7.23e7.30 (m, 36 H); 13C NMR (75.5 MHz,
128.5,133.3 (d, J ¼ 19.0 Hz),135.6 (d, J ¼ 21.2 Hz),136.8,160.6,160.8;
31P NMR (CDCl3, 162 MHz)
77.37; H, 6.76; found C, 77.80; H, 6.46.
CDCl3)
d
22.7, 28.9, 67.6, 67.7, 93.8, 114.7 (d, J ¼ 7.5 Hz), 128.4 (d,
d
ꢀ6.94; Anal. calcd. for C97H101O13P: C,
J ¼ 7.5 Hz), 133.4 (d, J ¼ 19.6 Hz), 135.6 (d, J ¼ 21.1 Hz), 137.9 (d,
J ¼ 10.6 Hz), 159.8, 160.8; 31P NMR (CDCl3, 162 MHz)
d
ꢀ6.93; Anal.
8. A mixture of V (0.28 g, 0.49 mmol), IX (1.1 g, 1.95 mmol),
K2CO3 (0.4 g, 2.9 mmol) and 18-C-6 (cat.) in DMF (10 mL) was
stirred at 70 ꢁC for 36 h and proceeded as described in general
procedure to afford phosphine oxide, as a yellow oil (0.73 g, 72%).
calcd. for C75H75O6P3: C,77.30; H,6.49; found C,77.43; H,6.59.
4. A mixture of 1 (0.034 g, 0.043 mmol) and [Rh(cod)Cl]2 (0.010 g,
0.021 mmol) in CH2Cl2 (1 mL) was stirred at room temperature for
10 min and proceeded as described in general procedure to afford 4,
TLC: Rf 0.4 (CHCl3/MeOH ¼ 95:5). 1H NMR (CDCl3, 300 MHz)
d 1.61
as a yellow gum (0.044 g, 98%). 1H NMR (CDCl3, 300 MHz)
d
1.62 (br,
(br, 12 H), 1.81 (br, 24 H), 3.93 (t, J ¼ 6.0 Hz, 18 H), 4.00 (t, J ¼ 6.0 Hz,
6 H), 4.98 (s, 6 H), 6.06e6.15 (m, 12 H), 6.95 (d, J ¼ 8.4 Hz, 6 H),
6 H), 1.83e2.05 (br, 16 H), 2.39 (br, 4 H), 3.13 (s, 2 H), 3.96 (m, 12 H),
5.55 (s, 2 H), 6.06 (s, 3 H), 6.91 (m, 8 H), 7.25e7.76 (m,16 H); 13C NMR
7.30e7.68 (m, 51 H); 13C NMR (75.5 MHz, CDCl3)
d 22.7, 28.8, 28.9,
(75.5 MHz, CDCl3)
d
22.7, 29.0, 33.0, 67.6, 67.8, 70.5 (d, J ¼ 13.6 Hz),
67.7, 67.8, 70.0, 93.7, 94.1, 114.5 (d, J ¼ 12.0 Hz), 127.5, 127.9, 128.4 (d,
J ¼ 12.8 Hz), 128.5, 131.7 (d, J ¼ 3.0 Hz), 132.0 (d, J ¼ 9.8 Hz), 132.4,
133.4, 134.0 (d, J ¼ 11.3 Hz), 136.8, 160.6, 160.8, 162.0; 31P NMR
94.0, 104.9 (m, J ¼ 7.5 Hz), 114.4e114.5 (d, J ¼ 10.8 Hz), 120.5, 128.0
(d, J ¼ 10.5 Hz),129.4, 129.9, 132.0,132.5, 134.5 (d, J ¼ 10.5 Hz),136.9
(d, J ¼ 12.8 Hz), 159.0, 160.7, 160.9; 31P NMR (CDCl3, 162 MHz)
d
29.5
(CDCl3, 162 MHz) d 29.4; MALDI-TOF-MS m/z: calcd. for
(d, JPRh ¼ 150 Hz); Anal. calcd. for C59H69ClO6PRh: C, 67.91; H, 6.66;
C129H135O18P3 [M þ H]þ: 2065.36; found: 2065.487. Anal. calcd. for
Rh, 9.86; found C, 67.70; H, 6.74; Rh, 9.5.
C129H135O18P3: C,74.98; H,6.59; found C,74.63; H, 6.92.
5. A mixture of 2 (0.04 g, 0.04 mmol) and [Rh(cod)Cl]2 (0.02 g,
0.04 mmol) in CH2Cl2 (1 mL) was stirred at room temperature for
10 min and proceeded as described in general procedure to afford 5,
A solution of above intermediate (0.2 g, 0.1 mmol) in THF (5 mL)
was added to the stirred suspension of CeCl3 (0.14 g, 0.57 mmol)
and LAH (0.06 g, excess) in THF (25 mL) and proceeded as described
in general procedure to afford 8, as a colorless gum (0.18 g, 92%).
as a yellow foam (0.057 g, 96%). 1H NMR (CDCl3, 300 MHz)
d 1.63 (br,
6 H), 1.83e2.05 (br, 20 H), 2.42 (br, 8 H), 3.13 (s, 4 H), 3.96 (m, 12 H),
TLC: Rf 0.7 (PhMe/EtOAc ¼ 98:2). 1H NMR (CDCl3, 300 MHz)
d 1.59
5.55 (s, 4 H) 6.06 (s, 3 H), 6.91 (m, 7 H), 7.25e7.95 (m, 26 H); 13C NMR
(br, 12 H), 1.81 (br, 24 H), 3.94 (m, 24 H), 4.98 (s, 6 H), 6.05e6.14 (m,
(75.5 MHz, CDCl3)
d
22.7, 28.9, 33.0, 67.7, 67.8, 70.5 (d, J ¼ 13.6 Hz),
12 H), 6.86 (d, J ¼ 8.4 Hz, 6 H), 7.22e7.41 (m, 51 H); 13C NMR
93.8, 104.9 (m, J ¼ 7.5 Hz), 114.2, 114.3 (d, J ¼ 10.8 Hz), 120.5, 128.0
(75.5 MHz, CDCl3) d 22.7, 29.0, 67.6, 67.7, 70.0, 94.2, 114.7 (d,
(d, J ¼ 10.5 Hz),129.4, 129.9, 132.0,132.5, 134.4 (d, J ¼ 10.5 Hz),136.9
J ¼ 7.6 Hz), 127.5, 127.9, 128.4 (d, J ¼ 7.5 Hz), 128.6, 133.4 (d,
(d, J ¼ 12.8 Hz), 159.1, 160.7, 160.8; 31P NMR (CDCl3, 162 MHz)
d 29.5
J ¼ 18.8 Hz), 135.6 (d, J ¼ 21.1 Hz), 136.8, 137.9 (d, J ¼ 10.5 Hz), 159.8,
(d, JPRh ¼ 150 Hz). Anal. calcd. for C79H90Cl2O6P2Rh2: C, 64.36; H,
160.6, 160.8; 31P NMR (CDCl3, 162 MHz)
C129H135O15P3: C,76.76; H, 6.74; found C,76.88; H, 6.73.
d
ꢀ 6.96; Anal. calcd. for
6.15; Rh, 13.8; found C, 64.08; H, 6.17; Rh, 14.4.
6. A mixture of 3 (0.05 g, 0.043 mmol) and [Rh(cod)Cl]2 (0.032 g,
0.064 mmol) in CH2Cl2 (1 mL) was stirred at room temperature for
10 min and proceeded as described in general procedure to afford 6,
9. A mixture of VIII (0.21 g, 0.27 mmol), III (0.86 g, 1.9 mmol),
K2CO3 (0.34 g, 2.4 mmol) and 18-C-6 (cat.) in DMF (25 mL) was
stirred at 70 ꢁC for 48 h and proceeded as described in general
procedure to afford phosphine oxide, as a brown oil (0.55 g, 70%).
as a yellow foam (0.080 g, 98%). 1H NMR (CDCl3, 400 MHz)
d 1.62
(br, 6 H), 1.73e2.05 (m, 24 H), 2.40 (br, 12 H), 3.13 (s, 6 H), 3.93 (t,
J ¼ 6.0 Hz, 6 H), 3.99 (t, J ¼ 6.4 Hz, 6 H), 5.55 (s, 6 H) 6.06 (s, 3 H),
6.91 (d, J ¼ 8.0 Hz, 6 H), 7.18e7.77 (m, 36 H); 13C NMR (100 MHz,
TLC: Rf 0.5 (CHCl3/MeOH ¼ 93:7). 1H NMR (CDCl3, 300 MHz)
d 1.62
(br, 18 H), 1.82 (br, 36 H), 3.92 (t, J ¼ 6.6 Hz, 24 H), 4.00 (t, J ¼ 6.6 Hz,
12 H), 6.05 (s, 12 H), 6.95 (d, J ¼ 8.7 Hz, 12 H), 7.42e7.68 (m, 72 H);
CDCl3)
d
22.7, 28.9, 33.0, 67.7, 70.5 (d, J ¼ 13.7 Hz), 93.8, 104.9 (m,
13C NMR (75.5 MHz, CDCl3)
d 22.7, 28.8, 28.9, 67.7, 67.8, 93.8, 114.5
J ¼ 7.0 Hz), 114.2 (d, J ¼ 10.8 Hz), 128.0 (d, J ¼ 9.8 Hz), 129.9, 131.9,
(d, J ¼ 13.6 Hz), 128.4 (d, J ¼ 12.8 Hz), 131.7, 132.0 (d, J ¼ 9.8 Hz),
132.4, 134.4 (d, J ¼ 11.1 Hz), 136.8 (d, J ¼ 12.9 Hz), 160.6, 160.8; 31P
132.2, 133.5, 133.8 (d, J ¼ 11.3 Hz), 160.8, 161.9; 31P NMR (CDCl3,
NMR (CDCl3, 162 MHz)
d
29.5 (d, JPRh ¼ 149 Hz); Anal. calcd. for
162 MHz) d 29.44; MALDI-TOF-MS m/z: calcd. for C177H186O24P6
C99H111Cl3O6P3Rh3: C, 62.42; H, 5.87; Rh, 16.2; found C, 61.25; H,
6.04; Rh, 17.1.
[M þ Na]þ: 2904.17 Found: 2904.65; Anal. calcd. for C177H186O24P6:
C, 72.32; H, 6.54; found C, 72.14; H, 6.72.
7. A mixture of VII (0.7 g, 0.61 mmol), phosphine monomer III
(0.41 g, 0.92 mmol), K2CO3 (0.17 g, 1.23 mmol) and 18-C-6 (cat.) in
DMF (15 mL) was stirred at 70 ꢁC for 24 h and proceeded as
described in general procedure to afford phosphine oxide, as
a colorless gum (0.69 g, 74%). TLC: Rf 0.5 (PhMe/EtOAc ¼ 50:50). 1H
A solution of above intermediate (0.25 g, 0.086 mmol) in THF
(5 mL) was added to the stirred suspension of CeCl3 (0.19 g,
0.8 mmol) and LAH(0.08 g, excess) in THF (25 mL) and proceeded as
described in general procedure to afford 9, as a colorless gum (0.2 g,
84%). TLC: Rf 0.7 (PhMe/EtOAc ¼ 95:5). 1H NMR (CDCl3, 300 MHz)
NMR (CDCl3, 400 MHz)
d
1.64 (m, 8 H), 1.83 (m, 16 H), 3.91 (t,
d 1.63 (m, 18 H), 1.83 (m, 36 H), 3.93 (m, 36 H), 6.05 (s, 12 H), 6.86 (d,
J ¼ 6.0 Hz,14 H), 3.99 (t, J ¼ 6.0 Hz, 2 H), 4.98 (s,10 H), 6.06e6.23 (m,
J ¼ 7.8 Hz, 12 H), 7.15e7.30 (m, 72 H); 13C NMR (75.5 MHz, CDCl3)
12 H), 6.95 (d, J ¼ 8.7 Hz, 2 H), 7.29e7.67 (m, 37 H); 13C NMR
d
22.7, 29.0, 67.6, 67.7, 93.9, 114.7 (d, J ¼ 8.2 Hz), 128.4 (d, J ¼ 7.5 Hz),
(100 MHz, CDCl3)
d
22.7, 28.9, 67.7, 67.8, 70.0, 93.8, 94.1, 94.5, 114.5
129.0, 133.4 (d, J ¼ 19.6 Hz), 135.6 (d, J ¼ 21.2 Hz), 138.0 (d, J ¼ 11.3
(d, J ¼ 12.9 Hz), 127.5, 127.9, 128.4 (d, J ¼ 11.9 Hz), 128.5, 131.7, 132.0
Hz), 159.9, 160.9; 31P NMR (CDCl3, 162 MHz)
d
ꢀ 6.97; Anal. calcd.
(d, J ¼ 9.8 Hz), 132.4, 133.6, 133.9 (d, J ¼ 11.2 Hz), 136.8, 160.6, 160.8;
for C177H186O18P6: C, 76.27; H, 6.73; found C, 76.52; H, 6.51.
10. A mixture of 7 (0.04 g, 0.026 mmol) and [Rh(cod)Cl]2 dimer
(0.0065 g, 0.013 mmol) in CH2Cl2 (1 mL) was stirred at room
temperature for 10 min and proceeded as described in general
procedure to afford 10, as a yellow gum (0.044 g, 97%). 1H NMR
31P NMR (CDCl3, 162 MHz)
d 29.35; MALDI-TOF-MS m/z: calcd. for
C97H101O14P [M þ H]þ: 1522.70; found: 1522.61. Anal. calcd. for
C97H101O14P: C, 76.56; H, 6.69; found C,76.30; H, 6.57.
A solution of above intermediate (0.28 g, 0.18 mmol) in THF
(4 mL) was added to the stirred suspension of CeCl3 (0.1 g,
0.37 mmol) and LAH (0.05 g, excess) in THF (25 mL) and proceeded
as described in general procedure to afford 7, as a colorless gum
(0.23 g, 86%). TLC: Rf 0.65 (PhMe/EtOAc ¼ 98:2). 1H NMR (CDCl3,
(CDCl3, 400 MHz) d 1.62 (br, 8 H), 1.79e2.05 (br, 20 H), 2.40 (br, 4 H),
3.12 (s, 2 H), 3.92 (t, J ¼ 6.1 Hz, 14 H), 3.98 (t, J ¼ 6.1 Hz, 2 H), 4.98 (s,
10 H), 5.55 (s, 2 H), 6.06e6.23 (m, 12 H), 6.90 (d, J ¼ 8.6 Hz, 2 H),
7.29e7.73 (m, 37 H); 13C NMR (100 MHz, CDCl3)
d 22.7, 28.9, 33.0,
400 MHz)
d
1.61 (m, 8 H), 1.82 (m, 16 H), 3.92 (m, 16 H), 4.98 (s,
67.7, 67.8, 70.0, 70.5 (d, J ¼ 13.6 Hz), 93.7, 94.0, 94.4, 104.9 (m,
J ¼ 7.1 Hz), 114.3 (d, J ¼ 10.8 Hz), 127.5, 127.9, 128.3 (d, J ¼ 12.0 Hz),
128.5, 129.9, 132.0, 132.3, 134.4 (d, J ¼ 11.2 Hz), 136.8, 136.9 (d,
10 H), 6.06e6.23 (m, 12 H) 6.87 (d, J ¼ 8.0 Hz, 2 H), 7.22e7.41 (m,
37 H); 13C NMR (100 MHz, CDCl3)
22.7, 28.9, 67.6, 67.7, 70.0, 93.7,
94.0, 94.4, 114.6 (d, J ¼ 8.0 Hz), 127.5, 127.9, 128.4 (d, J ¼ 8.8 Hz),
d
J ¼ 7.8 Hz), 160.6, 160.8; 31P NMR (CDCl3, 162 MHz)
d 29.6 (d,